Hydralazine and magnesium valproate

DRUG4 trials

Sponsors

National Institute of Cancerología

Conditions

Cervical CancerMetastatic Cervical CancerOvarian CancerRefractory Solid Tumors

Phase 2

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

CompletedNCT00404326

National Institute of CancerologíaCervical Cancer

Start: 2005-05-31End: 2006-11-30Target: 18Updated: 2006-11-28

A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

CompletedNCT00404508

National Institute of CancerologíaRefractory Solid Tumors

Start: 2005-09-30End: 2006-10-31Target: 15Updated: 2006-11-28

Phase 3

Hydralazine Valproate for Cervical Cancer

National Institute of CancerologíaMetastatic Cervical Cancer

Start: 2007-07-31End: 2010-12-31Target: 143Updated: 2009-03-30

Hydralazine Valproate for Ovarian Cancer

National Institute of CancerologíaOvarian Cancer

Start: 2007-08-31End: 2009-12-31Target: 211Updated: 2007-09-21

Related Papers

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.

2007-09-01178 citations